자기 확장형 피복 스텐트 시장 규모, 점유율 및 동향 분석 보고서 : 해부학적 부위별, 적응증별, 재료별 및 부문별 예측(2026-2033년)

Self-expanding Covered Stents Market Summary

The global self-expanding covered stents market size was estimated at USD 743.8 million in 2025 and is projected to reach USD 1,091.7 million by 2033, growing at a CAGR of 5.0% from 2026 to 2033. The increasing prevalence of peripheral artery disease and aortoiliac occlusive disease, rising incidence of Aneurysm, are driving the demand for effective vascular interventions, thereby boosting the adoption of self-expanding covered stents.

The section below outlines the key factors driving the growth of the self-expanding covered stents (SX-CS) market, highlighting the rising prevalence of peripheral artery disease and aortoiliac occlusive disease, along with the increasing demand for minimally invasive vascular interventions. It also examines the role of technological advancements, such as Nitinol-based stent designs and improved Polytetrafluoroethylene coverings, as well as the expanding use of SX-CS in complex procedures, including Endovascular Aneurysm Repair, Fenestrated Endovascular Aneurysm Repair, and Branched Endovascular Aneurysm Repair, thereby strengthening their adoption across healthcare settings.

Rising prevalence of peripheral vascular diseases

The increasing incidence of Peripheral Artery Disease and Aortoiliac Occlusive Disease is driving demand for durable and flexible stent solutions. SX-CS is widely preferred due to its ability to provide long-term patency and vessel support in complex lesions. In May 2024, the Centers for Disease Control and Prevention highlighted that PAD affects millions of adults in the U.S., significantly increasing the need for endovascular interventions.

Global Self-expanding Covered Stents Market Report Segmentation

This report forecasts revenue growth at the global level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global self-expanding covered stents market report based on indication, material, anatomy, end use, and region:

• Anatomy Outlook (Unit Volume, Thousand, Procedure Volume, Thousand; Revenue, USD Million, 2021 - 2033)
• External Iliac
• SFA (Superficial Femoral Artery)
• Complex EVAR
• FEVAR
• BEVAR
• Indication Outlook (Unit Volume, Thousand, Procedure Volume, Thousand; Revenue, USD Million, 2021 - 2033)
• Aneurysm Repair
• Occlusive Disease (PAD)
• Dissections
• Trauma / Emergency Repair
• Material Outlook (Unit Volume, Thousand, Procedure Volume, Thousand; Revenue, USD Million, 2021 - 2033)
• ePTFE Covered Stents
• Polyurethane / Hybrid Covers
• Nitinol-based self-expanding stents
• Others (Heparin-bonded / bioactive coated stents, Stainless steel-based systems)
• End Use Outlook (Unit Volume, Thousand, Procedure Volume, Thousand; Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers (ASCs) / Day-care centers
• Specialty Clinics
• Regional Outlook (Unit Volume, Thousand, Procedure Volume, Thousand; Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Belgium
  • Netherlands
  • Luxembourg
  • Norway
  • Sweden
  • Denmark
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Material
  • 1.2.2. Anatomy
  • 1.2.3. Indication
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Self-Expanding Covered Stents Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Self-Expanding Covered Stents Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Model
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
• 3.4. Self-Expanding Covered Stents Market Pricing Analysis
• 3.5. Self-Expanding Covered Stents Market Average Device Utilization per Case
• 3.6. Vessel-Level Renal Artery Split for FEVAR/BEVAR Bridging Stent Usage
• 3.7. Clarification on inclusion of Specific Components
• 3.8. Development, Regulatory & Partnership Pathways for Complex EVAR (FEVAR / BEVAR)

Chapter 4. Self-Expanding Covered Stents Market: Anatomy Estimates & Trend Analysis

• 4.1. Global Self-Expanding Covered Stents Market: Anatomy Dashboard
• 4.2. Global Self-Expanding Covered Stents Market: Anatomy Movement Analysis
• 4.3. Global Self-Expanding Covered Stents Market Size & Forecast and Forecasts, By Anatomy, 2021 - 2033 (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
• 4.4. External Iliac
  • 4.4.1. External Iliac market estimates and market size & forecast and forecasts, 2021 - 2033 (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
• 4.5. SFA (Superficial Femoral Artery)
  • 4.5.1. SFA (Superficial Femoral Artery) market estimates and market size & forecast and forecasts, 2021 - 2033 (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
• 4.6. Complex EVAR
  • 4.6.1. Complex EVAR market estimates and market size & forecast and forecasts, 2021 - 2033 (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
• 4.7. FEVAR
  • 4.7.1. FEVAR market estimates and market size & forecast and forecasts, 2021 - 2033 (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
• 4.8. BEVAR
  • 4.8.1. BEVAR market estimates and market size & forecast and forecasts, 2021 - 2033 (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)

Chapter 5. Self-Expanding Covered Stents Market: Indication Estimates & Trend Analysis

• 5.1. Global Self-Expanding Covered Stents Market: Indication Dashboard
• 5.2. Global Self-Expanding Covered Stents Market: Indication Movement Analysis
• 5.3. Global Self-Expanding Covered Stents Market Size & Forecast and Forecasts, By Indication, 2021 - 2033 (USD Million)
• 5.4. Aneurysm Repair
  • 5.4.1. Aneurysm repair market estimates and market size & forecast and forecasts, 2021 - 2033 (USD Billion)
• 5.5. Occlusive Disease (PAD)
  • 5.5.1. Occlusive disease (PAD) market estimates and forecasts 2021 to 2033, (USD Million)
• 5.6. Dissections
  • 5.6.1. Dissections market estimates and forecasts 2021 to 2033, (USD Million)
• 5.7. Trauma / Emergency Repair
  • 5.7.1. Trauma/emergency repair market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 6. Self-Expanding Covered Stents Market: Material Estimates & Trend Analysis

• 6.1. Global Self-Expanding Covered Stents Market: Material Dashboard
• 6.2. Global Self-Expanding Covered Stents Market: Material Movement Analysis
• 6.3. Global Self-Expanding Covered Stents Market Size & Forecast and Forecasts, By Material, 2021 - 2033 (USD Million)
• 6.4. ePTFE Covered Stents
  • 6.4.1. ePTFE covered stents market estimates and forecasts 2021 to 2033, (USD Million)
• 6.5. Polyurethane / Hybrid Covers
  • 6.5.1. Polyurethane / hybrid covers market estimates and forecasts 2021 to 2033, (USD Million)
• 6.6. Nitinol-based self-expanding stents
  • 6.6.1. Nitinol-based self-expanding stents market estimates and forecasts 2021 to 2033, (USD Million)
• 6.7. Others (Heparin-bonded / bioactive coated stents, Stainless steel-based systems)
  • 6.7.1. Others (Heparin-bonded / bioactive coated stents, Stainless steel-based systems) market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 7. Self-Expanding Covered Stents Market: End Use Estimates & Trend Analysis

• 7.1. Global Self-Expanding Covered Stents Market: End Use Dashboard
• 7.2. Global Self-Expanding Covered Stents Market: End Use Movement Analysis
• 7.3. Global Self-Expanding Covered Stents Market Size & Forecast and Forecasts, By End Use, 2021 - 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals covered stents market estimates and forecasts 2021 to 2033, (USD Million)
• 7.5. Ambulatory Surgical Centers (ASCs) / Day-care centers
  • 7.5.1. Ambulatory surgical centers (ASCs) / day-care centers covered stents market estimates and forecasts 2021 to 2033, (USD Million)
• 7.6. Specialty Clinics
  • 7.6.1. Specialty clinics covered stents market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 8. Self-Expanding Covered Stents Market: Regional Estimates & Trend Analysis by Material, Indication, Anatomy, End Use, And Region

• 8.1. Regional Market Share Analysis, 2025 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. U.S.
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. U.S. market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.4.2. Canada
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Canada market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.4.3. Mexico
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Mexico market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
• 8.5. Europe
  • 8.5.1. UK
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. UK market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.2. Germany
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Germany market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.3. Spain
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Spain market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. France market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Italy market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.6. Norway
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Norway market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.7. Denmark
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Denmark market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Regulatory framework
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Sweden market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.9. Belgium
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Regulatory framework
    • 8.5.9.3. Competitive scenario
    • 8.5.9.4. Belgium market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.10. Netherlands
    • 8.5.10.1. Key country dynamics
    • 8.5.10.2. Regulatory framework
    • 8.5.10.3. Competitive scenario
    • 8.5.10.4. Netherlands market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.5.11. Luxembourg
    • 8.5.11.1. Key country dynamics
    • 8.5.11.2. Regulatory framework
    • 8.5.11.3. Competitive scenario
    • 8.5.11.4. Luxembourg market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
• 8.6. Asia Pacific
  • 8.6.1. Japan
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Japan market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.6.2. China
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. China market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.6.3. India
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. India market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.6.4. South Korea
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. South Korea market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.6.5. Thailand
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Thailand market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.6.6. Australia
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Australia market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
• 8.7. Latin America
  • 8.7.1. Brazil
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Brazil market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.7.2. Argentina
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Argentina market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
• 8.8. MEA
  • 8.8.1. South Africa
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. South Africa market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.8.2. Saudi Arabia
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.8.3. UAE
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. UAE market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)
  • 8.8.4. Kuwait
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Regulatory framework
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033, (Revenue: USD Million, Unit Volume in Thousand, Procedure Volume in Thousand)

Chapter 9. Competitive Landscape

• 9.1. Participant Overview
• 9.2. Company Market Position Analysis, 2025
• 9.3. Company Market Share Analysis, 2025 (%)
• 9.4. Company Categorization
• 9.5. Strategy Mapping
• 9.6. Company Profiles/Listing
  • 9.6.1. W. L. Gore & Associates, Inc.
    • 9.6.1.1. Company overview
    • 9.6.1.2. Financial performance
    • 9.6.1.3. Type benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. Solaris Endovascular
    • 9.6.2.1. Company overview
    • 9.6.2.2. Financial performance
    • 9.6.2.3. Type benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. BD (Angiomed GmbH & Co. Medizintechnik KG)
    • 9.6.3.1. Company overview
    • 9.6.3.2. Financial performance
    • 9.6.3.3. Type benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. LeMaitre Vascular, Inc.
    • 9.6.4.1. Company overview
    • 9.6.4.2. Financial performance
    • 9.6.4.3. Type benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Endologix LLC
    • 9.6.5.1. Company overview
    • 9.6.5.2. Financial performance
    • 9.6.5.3. Type benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. Artivion, Inc
    • 9.6.6.1. Company overview
    • 9.6.6.2. Financial performance
    • 9.6.6.3. Type benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. Merit Medical Systems
    • 9.6.7.1. Company overview
    • 9.6.7.2. Financial performance
    • 9.6.7.3. Type benchmarking
    • 9.6.7.4. Strategic initiatives